Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

118 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.
Jongen PJ, Sindic C, Carton H, Zwanikken C, Lemmens W, Borm G; Functional composite and quality of Life in Avonex-treated Relapsing multiple sclerosis patients study group. Jongen PJ, et al. J Neurol. 2010 Apr;257(4):584-9. doi: 10.1007/s00415-009-5378-x. Epub 2009 Nov 18. J Neurol. 2010. PMID: 19921303 Clinical Trial.
Drug adherence and multidisciplinary care in patients with multiple sclerosis: protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study).
Jongen PJ, Hengstman G, Hupperts R, Schrijver H, Gilhuis J, Vliegen JH, Hoogervorst E, van Huizen M, van Munster E, Samijn J, de Schryver E, Siepman T, Tonk M, Zandbergen E, ten Holter J, van der Kruijk R, Borm G. Jongen PJ, et al. BMC Neurol. 2011 Mar 30;11:40. doi: 10.1186/1471-2377-11-40. BMC Neurol. 2011. PMID: 21450086 Free PMC article. Clinical Trial.
Adverse events of interferon beta-1a: a prospective multi-centre international ICH-GCP-based CRO-supported external validation study in daily practice.
Jongen PJ, Sindic C, Sanders E, Hawkins S, Linssen W, van Munster E, Frequin S, Borm G; Functional Composite and Quality of Life in Avonex-treated Relapsing Multiple Sclerosis Patients Study Group. Jongen PJ, et al. PLoS One. 2011;6(10):e26568. doi: 10.1371/journal.pone.0026568. Epub 2011 Oct 25. PLoS One. 2011. PMID: 22046309 Free PMC article. Clinical Trial.
118 results